Introduction
Leukemia is the most common malignant disease among children under the age of 15 years in socio-economically developed parts of the world, including Europe, North America, and Australasia [1, 2] . Despite considerable phenotypic and genetic diversity, the numerically dominant leukemia subtype is B cell precursor (BCP) ALL which has a characteristic but unexplained age-incidence peak between 2 and 5 years of age [3] . Cytogenetic and molecular analyses have revealed that leukemia cells carry non-random chromosome rearrangements juxtaposing or amplifying genes associated with leukemia initiation [4] . In BCP ALL, two types of rearrangement account for N50% of cases: ∼25% of patients carry a reciprocal translocation between chromosomes 12 and 21 [t(12;21)(12p13;21q22)], leading to the in-frame fusion of the TEL (ETV6) gene on chromosome 12p13 and the AML1 (RUNX1) gene on 21q22, respectively. A further 30% of cases have a high hyperdiploid (HeH) karyotype, where the modal chromosome number, characterized by non-random gain of chromosomes X, 4, 6, 8, Blood Cells, Molecules, and Diseases 42 (2009) [129] [130] [131] [132] [133] [134] [135] 10, 14, 17, 18, and 21, exceeds 50 [4] . Molecular data indicate that initiating rearrangements are necessary, but not sufficient, to give rise to clinical leukemia [4] . In BCP ALL, progression from pre-leukemia to overt clinical disease requires additional genetic lesions which are thought to be acquired under the influence of an abnormal, usually post-natal, immune response to infection [5] .
There has been much debate about the type and mechanism of infectious causation in childhood leukemia prompted by the failure to date to detect a causative infectious agent [5] [6] [7] . Molecular evidence has shown that the frequency of children with leukemia-initiating chromosomal rearrangements at birth exceeds the number developing clinical leukemia by two orders of magnitude [8] , and are not increased following exposure of the pre-term newborn to diagnostic radiation [9] . This suggests that progression from pre-leukemia to clinical disease involves transition through a bottleneck influenced by the timing of exposure to post-natal infection. Paradoxically, early exposure to infection seems to confer protection, whilst delayed exposure is thought to lead to an aberrant immune response facilitating progression to leukemia [5] . Whilst this "second-hit" seems to require the lapse of sufficient time to accumulate additional somatic mutations, it is not yet clear whether the infection conferring protection following early exposure also leads to increased risk if exposure is delayed. Here we review some of the recent studies on the role of the human major histocompatibility complex (MHC) in the etiology of childhood leukemia, and propose a novel hypothesis for infectious causation.
The human major histocompatibility complex
In the absence of direct evidence for the role of an infectious agent in childhood leukemia, our interests have focused on proxy measures of immunity to infection that can be attributed to geneticallydetermined differences in immune function. Central to these studies are the genes of the human MHC, and specifically the Human Leukocyte Antigen (HLA) genes.
The extended human major histocompatibility complex (xMHC) on the short arm of chromosome 6 (6p21.3) spans about 7.6 megabase DNA [10] . It includes 421 loci, of which 252 are expressed, and is partitioned into the class I, II and III regions, the class III region being located between I and II, and the most gene-dense region of the human genome (Fig. 1) . The MHC contains a number of clustered and duplicated genes, the foremost of which are the HLA class I and class II gene clusters. The class I gene cluster includes the highly polymorphic expressed classical HLA-A, B and C genes; the class II gene cluster includes the polymorphic classical HLA-DR, DQ and DP genes. Both gene clusters encode cell surface heterodimeric proteins whose primary function is to bind short peptide fragments derived from non-self and self proteins in a closed (class I) or open (class II)-ended peptide binding groove whose walls are formed by two alpha helices, the floor consisting of a beta-pleated sheet. Peptides anchored to class I molecules are targeted by the T cell receptors (TCR) of CD8+ cytotoxic T cells; those bound by class II molecules are presented to and activate CD4+ T cells [11] . In both cases, the secure anchoring of peptides (T cell epitopes) by an HLA allotypic molecule is an absolute requirement for the formation of a tri-molecular TCR-peptide-HLA complex leading to T cell activation. This binding is influenced by the charge and size characteristics of a series of polymorphic peptide binding pockets lining the peptide or antigen-binding groove of the HLA molecule. The affinity of a given antigenic peptide for a polymorphic HLA allotype enables T cells to constantly sample the individual's antigenic environment for the presence of pathogens requiring a speedy protective immune response to eliminate the pathogen. Rapid evolution of pathogen sequences is thought to have exerted the significant selective forces that have given rise to the extremely high level of HLA polymorphisms in the population [12] . However, there is considerable flexibility and overlap in peptide binding between allotypes, due to the sharing of peptide pocket polymorphisms between alleles, leading to within-locus HLA allele clusters known as supertypes [13] . Despite this overlap in the specificity of peptide binding, a relatively small number (4-6) of peptide binding pockets impose constraints on peptide sequences that can be accommodated by HLA molecules [14] . It would be over-simplistic to suggest that this constitutes the central control of immune response gene cascade; however, the formation of a TCRpeptide-HLA tri-molecular complex is at the epicenter of T cell interactions with non-self and self antigens, and probably holds the answers to many HLA-associated diseases [11] . Thus HLA allele associations with childhood leukemia are likely to provide important insights into the role of infection in progression from pre-leukemia to clinical disease.
In addition to the HLA genes, the xMHC includes some 67 other genes, comprising about 28% of expressed MHC genes, that are involved in either adaptive or innate immunity [10] . These include the genes of the immunoglobulin superfamily, inflammation-associated genes, such as tumor necrosis factor and lymphotoxin, leukocyte maturation, complement genes, non-classical HLA genes, and immune regulation and stress response genes. Furthermore, the region also contains a large number of genes not related to the immune system that play a role in cell cycle regulation, apoptosis, transcription and translational machinery, signaling, and other cellular processes. Although a detailed discussion of gene function is beyond the scope of this review, none of these MHC genes can yet be excluded as candidates in childhood leukemia susceptibility.
The MHC and childhood leukemia
Historically, the clinical significance of the HLA genes is their role as a barrier to the free exchange of organs and tissues between individuals. However, it is now clear that the primary biological function of HLA genes is the orchestration of the immune response to pathogens through the formation of TCR-peptide-HLA complexes. The fact that the HLA genes are associated with more diseases than any other region of the genome may reflect a common underlying pathogenetic pathway in which sub-version of the immune response can arise as a consequence of interactions between infection or other non-self antigens and HLA molecules. It is thus noteworthy that the majority of HLA-associated diseases have an autoimmune pathogenesis [12] possibly caused by the triggering of cross-reactive T cell responses to self proteins by pathogens. The breakdown of immune tolerance to self as a result of exposure to infection, leading to the destruction of self tissues recognized as auto-immune disease, has been termed molecular or pathogen mimicry and may be an underlying characteristic of many HLA-associated diseases [15] . In this paper, we consider how molecular mimicry might influence the risk of childhood leukemia in the context of an infectious etiology.
Prompted by the work of Lilly and colleagues in the 1960s showing that susceptibility to Gross retroviral leukemia in the mouse was linked to the H-2 complex [16, 17] , childhood leukemia was one of the first human diseases to be investigated for associations with HLA antigens. These early studies focused on HLA class I antigens, but produced inconsistent results [18] , probably due to small patient numbers influenced by selection, limited diagnostic criteria, and the use of serological HLA typing methods. Later studies of the HLA-D or class II region using serological typing suffered from the same problems, but suggested an association between class II alleles and survival [19] .
By the 1990s, radical improvements in the diagnostic classification and treatment of childhood leukemias, better survival rates, and progress in the design of molecular epidemiological studies made it possible to re-examine the relationship between HLA and childhood leukemia. Importantly, the development of high resolution molecular typing methods driven by the needs of donor-recipient hematopoietic stem cell transplantation [20] made it possible to analyze interindividual differences in the key antigen-binding sites of HLA alleles as a proxy measure of interactions with foreign (and self) peptides. More recent developments in high-throughput single nucleotide polymorphism (SNP) genotyping have extended this capability to the identification of conserved haplotype blocks across the entire xMHC [21] which should allow the construction of a detailed MHC map to localize all MHC-associated childhood leukemia genes, as recently demonstrated for type 1 diabetes [22] . Ultimately, the dual strategy of identifying the functional contribution of HLA alleles in the causation of childhood leukemia, and mapping of additionally important MHC genes will help to pinpoint the role of infection, and enable progress to be made toward the elusive goal of childhood leukemia prevention.
Confirmation of many HLA associations with a diversity of diseases has nevertheless proven to be extremely challenging, even in relatively common auto-immune diseases [23] . These challenges can largely be attributed to methodologic issues related to between-study heterogeneity in case definition, selection bias, statistical power to detect associations, and confounding due to population stratification. Additionally, the high levels of linkage disequilibrium (the nonrandom association between alleles of different genetic loci) within the MHC, giving rise to extended haplotypes, can make it difficult to identify the MHC genes primarily responsible for disease [24, 25] . This is further complicated by the observation that linkage disequilibrium differs to varying degrees between race/ethnicity groups [21] , emphasizing the critical nature of identifying racially homogenous study populations and implementing adjustment methods to account for differences in genetic structure.
In this paper, we describe recent and ongoing work that has been initiated to elucidate the role of the xMHC in childhood leukemia etiology using data and biospecimens from two large populationbased case-control studies, the United Kingdom Childhood Cancer Study (UKCCS) and the Northern California Childhood Leukemia Study (NCCLS). The UKCCS was a carefully designed population-based casecontrol study set up in 1992, largely in response to societal concerns about the role of certain environmental carcinogens in the causation of childhood cancer and leukemia in the UK [26] . A key issue for consideration by the UKCCS was the perceived intrinsic vulnerability of parental germ cells, the fetus and newborn to changing patterns of radiation, and chemical carcinogen exposure and infection. A backdrop to the study, organized under the aegis of the UK Coordinating Committee on Cancer Research (UKCCCR), was the provocative suggestion, by Gardner et al. [27] , that the Seascale leukemia cluster associated with the nuclear reprocessing plant at Sellafield, may have arisen by radiation-induced germ-line mutation. The need to address this and a number of other compelling hypotheses led to the initiation of this 5-year nationwide study [26] .
Initiated in 1995, the NCCLS is a major ongoing US-based population-based case-control study which was also designed to investigate environmental and genetic causes of childhood leukemia largely in response to the large number of childhood cancer clusters that came to public attention, requiring investigation by health authorities [28] . Incident childhood leukemia cases are ascertained from major pediatric centers serving the 35-county Northern and Central California study area. Controls are randomly selected from the birth certificate files and matched to cases on date of birth, gender, maternal race, and Hispanic status. Among the vast amount of exposure data collected are detailed accounts of childhood infections, child's vaccination history, family structure, number of siblings and day-care and other school attendance. These data were obtained with special emphasis on exposure during time windows of development. Biospecimens collected in the NCCLS include constitutive DNA specimens from buccal cell scrapings and saliva, as well as pretreatment blood and bone marrow from case subjects.
Reverse immunogenetics and molecular mimicry (UKCCS)
One of the major difficulties in establishing an etiological role for infection in childhood leukemia has been in the identification of a causal agent. A child is exposed to a blizzard of infection and allergenderived antigenic peptides during the early post-natal period, many of which will have been cleared by the immune system before the development of childhood leukemia. Whilst it is technically possible to analyze T cell memory -the TCR limb of the tri-molecular complexof previous encounters with infection in children, this is logistically difficult in the prodromal phase of childhood leukemia. The alternative is to use reverse immunogenetics -the HLA component of the tri-molecular complex -to answer this question. Reverse immunogenetics aims to identify the peptide "footprint" of the HLA allele associated with disease (childhood leukemia) in order that this can be used to make predictions about the sequence of complementary peptide (i.e. infectious) ligands which bind to that HLA allotype. In fact, software programs able to predict the presence of HLA allotype binding peptides, often known as T cell epitope prediction algorithms, are now widely available, and have been used extensively in vaccine design [29, 30] . Whilst it is now relatively easy to identify T cell epitopes in infections using, for example, T cell epitope mapping tools such as TEPITOPE [31] , this requires prior knowledge of the infection and the availability of sequence information.
The obvious limitation of this approach in childhood leukemia is that the causal infection may be any of numerous microbes to which children are commonly exposed. Using a "reverse" approach however, we previously reported in the UKCCS that childhood BCP ALL is associated with alleles at the HLA-DPB1 locus, including DPB1⁎0201, which have a glutamic acid (E) residue at position 69 of the DPβ subunit lining the P4 peptide pocket of the DPα/β heterodimer [32] . This endows DPB1 alleles having this polymorphic residue ("DPβ69E" alleles) with a negatively charged P4 pocket that accommodates antigenic peptides with positively charged amino acids, such as lysine (K), at the P4 anchor position. Since the HLA-DP locus is only weakly linked to the DR/DQ loci, we believe that the association of BCP ALL with DPB1⁎0201 is a primary association. Since peptide binding by different HLA alleles can overlap in specificity, it is possible to cluster the very large number of DP alleles (N100) into a small number of supertypes based on predictions about their shared peptide binding properties. In our leukemia case-control series it was possible to cluster about 90% of the DP alleles into 6 supertypes, 3 supertypes being DPβ69E alleles (DP2, DP6 and DP8), and 3 being DPβ69K alleles (DP1, DP3 and DP4). We reported that the DP2 supertype is associated with susceptibility to BCP ALL [33] , whereas none of the 3 β69K supertypes were associated with susceptibility. In fact DP1 strongly protects against BCP ALL, possibly as a result of its ability to bind and present BCP ALL-associated onco-peptides such as TEL-AML1 and AML1 to T cells [34] .
To explain the infection-mediated promotion of childhood ALL, Greaves [5] has hypothesized that a transient inflammatory response mediated by cytokines selectively suppresses normal hematopoiesis, leaving a pre-leukemia clone with a selective growth advantage. The observed association of BCP ALL with DP2 [33] suggests that such an inflammatory reaction may involve a T cell response to a limited repertoire of infection-derived T cell epitopes. Furthermore, the consistent association of HLA-class II alleles with autoimmune diseases could be interpreted in the context of childhood BCP ALL as suggesting that T cells activated by certain types of infection in children with DP2 have a greater propensity to develop auto-immunity. If the target of this transient or chronic auto-immune response was a bone marrow (i.e. self) antigen that was mimicked by infection, this could accommodate the hypothesis advanced by Greaves [5] .
To illustrate a possible mechanism, we cite the well-documented example of molecular mimicry in treatment-resistant Lyme disease (TRLD) arthritis. This is a late manifestation of Lyme disease caused by infection with the spirochaete Borrelia burgdorferei, in which the association with HLA-DRB1⁎0401 suggests an auto-immune etiology [35] . Although patients with TRLD may have no evidence of B. burgdorferei, they may have antibodies to its outer surface protein (OspA), indicating previous exposure to the spirochaete. Identification of a DRB1⁎0401-binding nonamer peptide in B. burgdorferei, OspA 165-173 prompted a human peptide sequence homology search that revealed a human lymphocyte functional antigen alpha L332-340 (LFA-1, CD11a) peptide with 6 of the 9 amino acids identical to OspA 165-173 (YVIEGTSKQ) [36] . This peptide is located in the I-region of CD11α, a subunit that mediates the binding of LFA-1 to its ligand, ICAM-1. Evidence that the OspA and LFA-1α peptides both bind to DRB1⁎0401 and elicit cross-reactive T cell responses strongly suggests that OspA 165-173 mimics LFA-1a 332-340 in causing TRLD [37, 38] .
Based on the TRLD paradigm [35] , we employed a bio-informatic approach to predict infection-derived peptides that might be responsible for activating a DP2-restricted CD4+ T cell response leading to BCP ALL. Diaz et al [39] have identified the principal amino acid anchors at relative peptide positions P1, 4, 6 and 9 in natural DP2 ligands leading, in theory, to 480 potential ligands (Fig. 2) . For these we selected residues present in each pocket at highest frequency, including phenylalanine (F) anchored by the hydrophilic pockets 1 and 6, positively charged lysine (K) anchored by pocket 4, and valine (V) or alanine (A) anchored by pocket 9 of DP2. These sequences give rise to two generic peptides, FXXKXFXXV and FXXKXFXXA (where X is an unknown amino acid residue), predicted to have a strong affinity for DP2. To identify microbial peptides with these sequences we used the pattern-scanning algorithm, PATSCAN [40] to search the SWISSprot protein database [41] . This identified a total of 1013 DP2 ligands, including peptides of human and microbial origin. Selected microbial peptides identified in this way included Bordetella pertussis, Candida albicans, Clostridium tetani, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Mycobacterium tuberculosis, Mycoplasma pneumoniae, Staphylcoccus aureas, Variola virus and Yersina pestis. Among 4 herpes virus sequences with predicted DP2 ligands (HHV-1, -2, -5 and -6), we selected a peptide from the HHV-5 (human cytomegalovirus) unique short early protein, US3 [61] [62] [63] [64] [65] [66] [67] [68] [69] (FTEKHFVNV) [42] . CMV is a potential candidate agent for childhood leukemia since it is known to elicit strong CD8+ CTL responses in asymptomatic infants, leading to high levels of long term immunological memory [43] . Using the US3 61-69 peptide sequence, we searched among non-redundant proteins using the Basic Local Alignment Search Tool (BLASTp) [44] , for homologous human sequences. The best match was a peptide from the inserted (I) domain of alpha 1 integrin (CD49a), αI 167-175 , PTEKHFFNV which shares 7 of 9 amino acids with US3 61-69 [45] .
The integrins are a widely expressed and diverse family of heterodimeric adhesion receptors that play a major role in cellmatrix and cell-cell interactions [46] . Alpha 1 integrin non-covalently associates with beta 1 integrin to form the α1/β1 complex, VLA-1 (CD49a/CD29) which is expressed by bone marrow stromal myofibroblasts [47] . These cells support the growth of human B cell precursors [48] which are induced to proliferate by activated CD4+ T cells [49] . In light of our empirical analysis, we hypothesize that early HCMV infection might lead to the development of DP2-restricted T cells to HCMV US3 [61] [62] [63] [64] [65] [66] [67] [68] [69] that can, in certain situations, cross-react with VLA-1 αI 167-175 . Chronic stimulation of T cells by the VLA-1 αI 167-175 peptide after clearance of the HCMV infection could lead to the secretion of bone-marrow suppressing cytokines, or direct attack on stromal myofibroblasts by cytotoxic T cells [50] . Either way, this could compromise the adhesion of normal B cell progenitors to stroma [51] [52] [53] and could account for the selective survival of preleukemia cells, as envisaged by Greaves [5] (Fig. 3) . Our hypothesis, that BCP ALL arises as an indirect result of a transient auto-immune induced inflammatory reaction due to molecular mimicry, might explain why this subtype appears to be associated with delayed infection. Children with the DP2-supertype may be at higher risk of developing auto-immunity to a DP2-restricted T cell epitope such as VLA-1 αI 167-175 , which, with some delay following clearance of the agent, results in immune attack on bone marrow stroma.
Whilst this scenario is currently speculative, it provides a realistic framework for further hypothesis testing involving the confirmation of HLA allele associations in childhood leukemia, in silico prediction of HLA-restricted infectious and homologous self peptides, and the identification in patients of cross-reactive antibodies and memory T cells to these non-self and self peptides. Based on the results of these studies, it should be possible to recapitulate the impact of infectioninduced auto-immune T cells on the growth of normal and malignant B cells in vitro in bone marrow stromal cultures to determine if the model is correct.
MHC association mapping (NCCLS)
Recent advancements in high-throughput genotyping technologies, together with the rich genomic information provided by the Human Genome Project and International HapMap Project initiatives, have allowed investigators to effectively interrogate whole genomes in association studies. These approaches have been aided by the understanding that segments of the genome are arranged into distinct haplotype blocks defined by the level of linkage disequilibrium exhibited between neighboring genetic markers [54] . Taking advantage of this knowledge, a highly specific panel of SNPs can be assembled to represent the variation within each haplotype block, which can then be used in combination with select known functional SNPs and other SNPs based on linear spacing in association studies to map regions of the genome involved in disease susceptibility. Genome-wide mapping strategies can also be applied on a smaller scale, for example, to cover only the xMHC region to address more targeted hypotheses. This approach, using both case-control and family-based study designs, has proven effective for other immunerelated complex diseases such as several classes of autoimmune diseases including lupus [55] , multiple sclerosis [23] , and type 1 diabetes [22] . Despite the accumulating support for a role of immunologic factors in the etiology of childhood leukemia [5, 6] , as well as the aforementioned reports of epidemiologic associations of childhood leukemia with specific HLA loci [32, 34] , no studies have yet comprehensively reported on the mapping of associations across the complete MHC region. Such an approach can confirm previouslyreported childhood leukemia associations with specific HLA loci, help narrow down potential causal variants within these confirmed HLA loci, and also identify new associations with other loci within the MHC.
To begin exploring the role of genetic susceptibility behind several of the documented immune-related associations observed between childhood leukemia and exposure to infections and allergens, we have initiated an association mapping project of the MHC region in the NCCLS. Genotyping of non-Hispanic White and Hispanic subjects (the two largest race/ethnicity populations enrolled in the NCCLS) is being pursued using the Illumina MHC Mapping Panel (Illumina Inc., San Diego, CA). This panel [56] comprises a highly validated series of 1293 evenly spaced SNPs spanning an approximately 4 megabase region of the MHC bordered by the TRIM27 and MLN genes at the telomeric and centromeric ends, respectively. There is an average 3.8 kilobase spacing between each SNP, covering all major regions of the MHC, including the classical class I, II and III regions, the extended class II region and part of the extended class I region. The panel set was designed with a strong emphasis on haplotype tagging SNPs, SNPs that are highly informative about nearby SNPs in linkage disequilibrium. This is a notably important feature since the chance of detecting an association is significantly influenced by the ability of the SNP or combination of SNPs to adequately represent the haplotypic diversity of the region. Higher resolution mapping is also possible, via a second Illumina MHC specific panel, the MHC Exon-Centric Panel, which contains 1228 SNPs and emphasizes regions near and within coding exons. Combining the two panels yields a total of 2360 SNP genotypes with an average 2 kilobase spacing between the SNP loci. These Illumina MHC panels offer a cost-effective approach to scan the MHC region. We expect that the mapping effort begun here will help direct future efforts in selecting other specific classical class I and II HLA loci for allelic typing and the implementation of reverse immunogenetics methodology as described above.
It should be noted that the recent ability to test large numbers of SNP loci in large and diverse study populations has resulted in two major areas of concern, specifically, issues of increased probabilities of false positive findings and population stratification, a type of confounding which may be present due to unaccounted population substructure and/or recent admixture [57] in a multi-ethnic study population. [58] [59] [60] . Whilst a statistically significant difference in frequency of a particular SNP or haplotype between cases and controls provides initial evidence for a role in disease susceptibility, replication in independent populations is required to provide credibility for the finding and justification for more focused study to determine the gene and causal variants involved. In terms of false positives, in the approach outlined here, it is important to note that the goal of association mapping is to localize regions of interest. Individual markers with significant p-values are less pertinent for association mapping than a group of neighboring markers for whom p-values are significant. Thus, we are not concerned with identifying variants of interest, so much as regions that should be explored further in this and other study populations.
Whilst there has been a great deal of discussion regarding criteria for establishing causality in genetic epidemiology studies [61] , it is widely agreed that replication is a critical step [62] . A result that has been replicated in one or more study populations is unlikely to be due solely to chance or possible population stratification. We intend to carefully interrogate regions identified through the MHC association mapping effort in other comparable study populations. Such efforts will be facilitated through the Childhood Leukemia International Consortium (CLIC, www.clic.berkeley.edu), a recently assembled consortium that currently includes 14 different epidemiologic studies of childhood leukemia representing populations from 10 different countries including the United Kingdom, Canada, Australia, New Zealand, France, Italy, Brazil, Germany, South Korea, and the United States. Both the UKCCS and the NCCLS are members this group, and plans are in progress to replicate MHC findings within CLIC studies.
Conclusions
Technologies are now available for a detailed examination of the role of the complete human xMHC in childhood leukemia. This will assist the dual objectives of defining the contribution of specific HLA molecules in the natural history of childhood leukemia, and identification of additional xMHC genes that contribute to the disease. The collection of comprehensive datasets on the timing and types of environmental exposures, including several surrogate measures of exposure to infections (e.g. daycare attendance, reported childhood infections, birth order, etc.) [6] , will facilitate an analysis of geneenvironment interactions with specific HLA alleles. Based on the results of HLA class II molecular typing, and the central role of this region in the pathogenesis of auto-immune disease, it is possible to make preliminary predictions about mechanisms involving molecular mimicry that might lead to childhood BCP ALL. Whilst still in the realm of speculation, this can be assisted by peptide pattern-scanning, and sequence homology searches. We have selected empirically a viral (HCMV US3) and self (alpha 1 integrin) peptide with sufficient homology to provide a hypothesis for the infection-induced suppression of normal bone marrow by molecular mimicry. Although further modeling will identify additional candidates, and the mapping efforts described may identify additional regions of interest in the MHC, our hypothesis integrates the HLA molecular data with the biological modeling of the early events in the development of childhood leukemia, that should be testable using epidemiological and biological methods.
